Literature DB >> 3900116

Developmental changes in the mother-child interactions of hyperactive boys: effects of two dose levels of Ritalin.

R A Barkley, J Karlsson, S Pollard, J V Murphy.   

Abstract

The mother-child interactions of 60 hyperactive children subdivided equally into five age levels (years 5, 6, 7, 8 and 9) were studied during free play and task periods in a double-blind drug-placebo evaluation of two dose levels of Ritalin (0.3 and 0.7 mg/kg bid.) on these interactions. No effects for age or drug condition were found during free play. In contrast, age effects were significant in the task period with the children increasing their compliance and sustained attention with age. In response, mothers decreased their direction and control while increasing their passive observation of the children. Several drug effects were found during the task period, indicating that only the high dose of Ritalin produced improvements in child compliance. However, both doses resulted in decreases in mothers' controlling reactions to the child's compliance and off-task behavior as well as in ratings of home behavior problems. Drug effects were essentially the same across all five age levels. The interaction patterns of hyperactive children are similar to those found in younger normal children in previous research, apparently reflecting a chronic lag in this pattern in hyperactive children that may be improved with stimulant medication.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900116     DOI: 10.1111/j.1469-7610.1985.tb00585.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  25 in total

1.  Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parenting.

Authors:  Andrea Chronis-Tuscano; Mark A Stein
Journal:  CNS Drugs       Date:  2012-09-01       Impact factor: 5.749

2.  Parenting Stress as a Mediator Between Childhood ADHD and Early Adult Female Outcomes.

Authors:  Chanelle T Gordon; Stephen P Hinshaw
Journal:  J Clin Child Adolesc Psychol       Date:  2015-06-04

3.  Preschoolers at risk for attention-deficit hyperactivity disorder and oppositional defiant disorder: family, parenting, and behavioral correlates.

Authors:  Charles E Cunningham; Michael H Boyle
Journal:  J Abnorm Child Psychol       Date:  2002-12

Review 4.  Treatment of attention-deficit hyperactivity disorder.

Authors:  L Murray; D R Patel
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

5.  Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study.

Authors:  K C Wells; J N Epstein; S P Hinshaw; C K Conners; J Klaric; H B Abikoff; A Abramowitz; L E Arnold; G Elliott; L L Greenhill; L Hechtman; B Hoza; P S Jensen; J S March; W Pelham; L Pfiffner; J Severe; J M Swanson; B Vitiello; T Wigal
Journal:  J Abnorm Child Psychol       Date:  2000-12

6.  The development of selective attention in children with attention deficit hyperactivity disorder.

Authors:  D A Brodeur; M Pond
Journal:  J Abnorm Child Psychol       Date:  2001-06

7.  Effects of sugar ingestion expectancies on mother-child interactions.

Authors:  D W Hoover; R Milich
Journal:  J Abnorm Child Psychol       Date:  1994-08

8.  Mothers' expressed emotion toward their school-aged sons. Associations with child and maternal symptoms of psychopathology.

Authors:  Lamprini Psychogiou; Dave M Daley; Margaret J Thompson; Edmund J S Sonuga-Barke
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

9.  Peer interactions of normal and attention-deficit-disordered boys during free-play, cooperative task, and simulated classroom situations.

Authors:  C E Cunningham; L S Siegel
Journal:  J Abnorm Child Psychol       Date:  1987-06

10.  A short-term longitudinal study of the early development of self-regulation.

Authors:  I W Silverman; D M Ragusa
Journal:  J Abnorm Child Psychol       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.